Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114972304 | 11497230 | 4 | F | 20140719 | 20160829 | 20150911 | 20160908 | EXP | US-PFIZER INC-2015298928 | PFIZER | 17.00 | YR | M | Y | 68.80000 | KG | 20160908 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114972304 | 11497230 | 1 | PS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | 165 MG/M2, CYCLIC, BID ON DAYS 1-21 | Y | 202570 | 165 | MG/M**2 | CAPSULE | ||||||
| 114972304 | 11497230 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | PROPHASE: 7.5-12MG ON DAY 1 | 11719 | ||||||||||
| 114972304 | 11497230 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | 3000 MG/M2, CYCLIC, DAY 1 (COURSE A) | 11719 | 3000 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 200 MG/M2, CYCLIC, OVER 15-30 MINUTES ON DAYS 1 AND 2(PROPHASE) | 0 | 200 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 5 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 800 MG/M2, CYCLIC DAYS 1-5 (COURSE A) | 0 | 800 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 6 | SS | VP-16 | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 100 MG/M2, CYCLIC, DAYS 4 AND 5 (COURSE A) | 0 | 100 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 7 | C | CYTARABINE. | CYTARABINE | 1 | Intrathecal | PROPHASE: 15-24MG DAY 1 | 0 | ||||||||||
| 114972304 | 11497230 | 8 | C | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 150 MG/M2, Q12H, CYCLIC, ON DAYS 4 AND 5 (COURSE A) | 0 | 150 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 9 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG/M2, CYCLIC, DAILY ON DAYS 1-2 PROPHASE | 0 | 5 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 10 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG/M2, CYCLIC, BID ON DAYS 3-5 | 0 | 5 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG/M2, CYCLIC, BID ON DAYS 1-5 (COURSE A) | 0 | 5 | MG/M**2 | ||||||||
| 114972304 | 11497230 | 12 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intrathecal | PROPHASE: 7.5-12MG ON DAY 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114972304 | 11497230 | 1 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 2 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 4 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 5 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 6 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 7 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 9 | Anaplastic large cell lymphoma T- and null-cell types |
| 114972304 | 11497230 | 12 | Anaplastic large cell lymphoma T- and null-cell types |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114972304 | 11497230 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114972304 | 11497230 | Hyponatraemia | |
| 114972304 | 11497230 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114972304 | 11497230 | 1 | 20140719 | 0 | ||
| 114972304 | 11497230 | 2 | 20140708 | 0 | ||
| 114972304 | 11497230 | 4 | 20140708 | 0 | ||
| 114972304 | 11497230 | 7 | 20140708 | 0 | ||
| 114972304 | 11497230 | 9 | 20150708 | 0 | ||
| 114972304 | 11497230 | 12 | 20140708 | 0 |